Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care

Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care

Adoptive cell therapy (ACT) with tumor-infiltrating T cells (TILs) has emerged as a promising therapy for the treatment of unresectable or metastatic solid tumors. One challenge to finding a universal anticancer treatment is the heterogeneity present between different tumors as a result of genetic i...

Full description

Bibliographic Details
Main Authors: Shuyang S. Qin, Alexa D. Melucci, Alexander C. Chacon, Peter A. Prieto
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cells
Subjects:
adoptive cell therapy
tumor-infiltrating T cells
immunotherapy
metastatic treatment
Online Access:https://www.mdpi.com/2073-4409/10/4/808

Similar Items

Similar Items